IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

This publication has 94 references indexed in Scilit:

• Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis
  Journal of Bone and Mineral Metabolism, 2002
• Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures
  Bone, 2002
• TNF Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL
  Endocrinology, 2002
• RANK (Receptor Activator of Nuclear Factor kappa B) and RANK Ligand Are Expressed in Giant Cell Tumors of Bone
  American Journal of Clinical Pathology, 2002
• Tumor necrosis factor‐α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism†
  Journal of Cellular Biochemistry, 2001
• The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-α, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells
  Bone, 2001
• Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor- B Ligand and Osteoprotegerin in Osteoblasts
  Endocrinology, 2000
• Cancer Cells Responsible for Humoral Hypercalcemia Express mRNA Encoding a Secreted Form of ODF/TRANCE That Induces Osteoclast Formation
  Biochemical and Biophysical Research Communications, 2000
• Interactions between Cancer and Bone Marrow Cells Induce Osteoclast Differentiation Factor Expression and Osteoclast-like Cell Formation in Vitro
  Biochemical and Biophysical Research Communications, 2000
• Osteoclastogenesis Inhibitory Factor (OCIF) Directly Inhibits Bone-Resorbing Activity of Isolated Mature Osteoclasts
  Biochemical and Biophysical Research Communications, 1998